Abstract
Having a good understanding of the natural history of schizophrenia, admittedly an abstraction, allows clinicians to make a correct diagnosis based on the longitudinal history. In this chapter, I describe the clinical phases of schizophrenia that need to be recognized, particularly the prodromal phase of schizophrenia that often begins with non-specific symptoms several years before schizophrenia declares itself with the onset of frank psychosis. A corresponding phase exists in chronic patients, where an impending relapse is heralded by non-specific early warning sign. This chapter also discussing the problem of prognostication as schizophrenia has many possible outcomes, ranging from a restitutio ad integrum in about 20–30% of cases to severe, unremitting illness in 10% of cases. For most patients treated schizophrenia is a manageable illness, particularly if help is provided when needed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wikipedia. Yogi Berra. Available from: https://en.wikiquote.org/wiki/Yogi_Berra. Accessed on 7/1/2019.
Shorter E. The history of nosology and the rise of the diagnostic and statistical manual of mental disorders. Dialogues Clin Neurosci. 2015;17:59–67.
Lieberman JA. Neurobiology and the natural history of schizophrenia. J Clin Psychiatry. 2006;67:e14.
Aleman A, Kahn RS, Selten JP. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry. 2003;60:565–71.
Zipursky RB, Reilly TJ, Murray RM. The myth of schizophrenia as a progressive brain disease. Schizophr Bull. 2013;39:1363–72.
Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, et al. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry. 2001;50:884–97.
Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530:177–83.
Farmer PE, Nizeye B, Stulac S, Keshavjee S. Structural violence and clinical medicine. PLoS Med. 2006;3:e449.
Nicolson R, Rapoport JL. Childhood-onset schizophrenia: rare but worth studying. Biol Psychiatry. 1999;46:1418–28.
Girard C, Simard M. Clinical characterization of late- and very late-onset first psychotic episode in psychiatric inpatients. Am J Geriatr Psychiatry. 2008;16:478–87.
Maglione JE, Thomas SE, Jeste DV. Late-onset schizophrenia: do recent studies support categorizing LOS as a subtype of schizophrenia? Curr Opin Psychiatry. 2014;27:173–8.
Howard R, Rabins PV, Seeman MV, Jeste DV. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group. Am J Psychiatry. 2000;157:172–8.
Riecher-Rossler A, Rossler W, Forstl H, Meise U. Late-onset schizophrenia and late paraphrenia. Schizophr Bull. 1995;21:345–54.
Brodaty H, Sachdev P, Koschera A, Monk D, Cullen B. Long-term outcome of late-onset schizophrenia: 5-year follow-up study. Br J Psychiatry. 2003;183:213–9.
Almeida OP, Howard RJ, Levy R, David AS. Psychotic states arising in late life (late paraphrenia). The role of risk factors. Br J Psychiatry. 1995;166:215–28.
Jones I, Chandra PS, Dazzan P, Howard LM. Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period. Lancet. 2014;384:1789–99.
Sit D, Rothschild AJ, Wisner KL. A review of postpartum psychosis. J Women’s Health. 2006;15:352–68.
Chaudron LH, Pies RW. The relationship between postpartum psychosis and bipolar disorder: a review. J Clin Psychiatry. 2003;64:1284–92.
Bergink V, Rasgon N, Wisner KL. Postpartum psychosis: madness, mania, and melancholia in motherhood. Am J Psychiatry. 2016;173:1179–88.
Spinelli M. Infanticide and American criminal justice (1980–2018). Arch Womens Ment Health. 2019;22:173–7.
Welham J, Isohanni M, Jones P, McGrath J. The antecedents of schizophrenia: a review of birth cohort studies. Schizophr Bull. 2009;35:603–23.
Tempelaar WM, Termorshuizen F, MacCabe JH, Boks MP, Kahn RS. Educational achievement in psychiatric patients and their siblings: a register-based study in 30 000 individuals in the Netherlands. Psychol Med. 2017;47:776–84.
Reichenberg A, Harvey PD. Neuropsychological impairments in schizophrenia: integration of performance-based and brain imaging findings. Psychol Bull. 2007;133:833–58.
Hafner H, Loffler W, Maurer K, Hambrecht M, an der Heiden W. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr Scand. 1999;100:105–18.
Hafner H, Maurer K, an der Heiden W. ABC schizophrenia study: an overview of results since 1996. Soc Psychiatry Psychiatr Epidemiol. 2013;48:1021–31.
Yung AR, McGorry PD. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust N Z J Psychiatry. 1996;30:587–99.
Klosterkotter J. Indicated prevention of schizophrenia. Dtsch Arztebl Int. 2008;105:532–9.
McGorry PD, McFarlane C, Patton GC, Bell R, Hibbert ME, Jackson HJ, et al. The prevalence of prodromal features of schizophrenia in adolescence: a preliminary survey. Acta Psychiatr Scand. 1995;92:241–9.
Mishara AL. Klaus Conrad (1905–1961): delusional mood, psychosis, and beginning schizophrenia. Schizophr Bull. 2010;36:9–13.
Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003;160:13–23.
Tranulis C, Park L, Delano L, Good B. Early intervention in psychosis: a case study on normal and pathological. Cult Med Psychiatry. 2009;33:608–22.
Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry. 2005;62:975–83.
Addington J, Heinssen RK, Robinson DG, Schooler NR, Marcy P, Brunette MF, et al. Duration of untreated psychosis in community treatment settings in the United States. Psychiatr Serv. 2015;66:753–6.
Koreen AR, Siris SG, Chakos M, Alvir J, Mayerhoff D, Lieberman J. Depression in first-episode schizophrenia. Am J Psychiatry. 1993;150:1643–8.
Gleeson JF, Rawlings D, Jackson HJ, McGorry PD. Early warning signs of relapse following a first episode of psychosis. Schizophr Res. 2005;80:107–11.
Spaniel F, Bakstein E, Anyz J, Hlinka J, Sieger T, Hrdlicka J, et al. Relapse in schizophrenia: definitively not a bolt from the blue. Neurosci Lett. 2018;669:68–74.
Remington G, Foussias G, Agid O, Fervaha G, Takeuchi H, Hahn M. The neurobiology of relapse in schizophrenia. Schizophr Res. 2014;152:381–90.
Wiedemann G, Hahlweg K, Hank G, Feinstein E, Muller U, Dose M. Detection of early warning signs in schizophrenic patients. Possible applications in prevention of recurrence. Nervenarzt. 1994;65:438–43.
Bleuler M, Huber G, Gross G, Schuttler R. Long-term course of schizophrenic psychoses. Joint results of two studies. Nervenarzt. 1976;47:477–81.
Harding CM, Zubin J, Strauss JS. Chronicity in schizophrenia: revisited. Br J Psychiatry Suppl. 1992;161:27–37.
Volavka J, Vevera J. Very long-term outcome of schizophrenia. Int J Clin Pract. 2018;72:e13094.
Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology. 1996;46:907–11.
Torrey EF. Onset, course, and prognosis. In: Surviving schizophrenia : a family manual. 7th ed. New York: Harper Perennial; 2019. p. 85–114.
Lally J, Maloudi S, Krivoy A, Murphy KC. Simple schizophrenia: a forgotten diagnosis in psychiatry. J Nerv Ment Dis. 2019;207(9):721–5.
Edgerton RB, Cohen A. Culture and schizophrenia: the DOSMD challenge. Br J Psychiatry. 1994;164:222–31.
Cohen A, Patel V, Thara R, Gureje O. Questioning an axiom: better prognosis for schizophrenia in the developing world? Schizophr Bull. 2008;34:229–44.
Ran M, Xiang M, Huang M, Shan Y. Natural course of schizophrenia: 2-year follow-up study in a rural Chinese community. Br J Psychiatry. 2001;178:154–8.
Alem A, Kebede D, Fekadu A, Shibre T, Fekadu D, Beyero T, et al. Clinical course and outcome of schizophrenia in a predominantly treatment-naive cohort in rural Ethiopia. Schizophr Bull. 2009;35:646–54.
Taipale H, Mittendorfer-Rutz E, Alexanderson K, Majak M, Mehtala J, Hoti F, et al. Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia. Schizophr Res. 2018;197:274–80.
Hopper K, Wanderling J. Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: results from ISoS, the WHO collaborative follow-up project. International Study of Schizophrenia. Schizophr Bull. 2000;26:835–46.
Karp DA. The burden of sympathy : how families cope with mental illness. Oxford: Oxford University Press; 2001.
Additional Resources
Book
Watters E. The shifting mask of schizophrenia in Zanzibar. Crazy like us: the globalization of the American psyche. New York: Free Press; 2011. – Read this book! It makes you question the wisdom of imposing our Western ideas about psychiatric illnesses (what counts as disease, how to you best treat it) on other, non-Western societies. Some societies may offer a more hopeful conceptual framework that allows for inclusion and healing and prevents psychological damage to patients. The book contains a chapter on schizophrenia.
Articles
Farmer PE, Nizeye B, Stulac S, Keshavjee S. Structural violence and clinical medicine. PLoS Med. 2006;3:e449. – A manuscript worth reading if you are interested in a critique of the idea of a “natural history” of any disease. Paul Farmer is an ID doctor from Boston who has brought first-rate health care to Haiti, proving that the outcome of disease is fundamentally a function of the society you live in – that social interventions are at least as important as any molecular advance.
Mishara AL. Klaus Conrad (1905–1961): delusional mood, psychosis, and beginning schizophrenia. Schizophr Bull. 2010;36:9–13. – An excellent summary in English if you are interested in learning more about Conrad’s descriptions of beginning psychosis.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Freudenreich, O. (2020). Natural History of Schizophrenia. In: Psychotic Disorders. Current Clinical Psychiatry. Humana, Cham. https://doi.org/10.1007/978-3-030-29450-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-29450-2_7
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-030-29449-6
Online ISBN: 978-3-030-29450-2
eBook Packages: MedicineMedicine (R0)